CTIC

CTI BioPharma Corp. Press Releases

$2.36
*  
0.05
2.16%
Get CTIC Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading CTIC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells
12/9/2014 1:30:00 AM - PR Newswire
▲5.36 % Price Change since this news event. The Volume Ratio is 2.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers
12/6/2014 12:00:00 PM - PR Newswire
▲1.72 % Price Change since this news event. The Volume Ratio is 1.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX®
12/4/2014 1:30:00 AM - PR Newswire
▲8.76 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting
12/1/2014 1:30:00 AM - PR Newswire
▲7.76 % Price Change since this news event. The Volume Ratio is 1.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock
11/7/2014 9:15:00 AM - PR Newswire
▲19.19 % Price Change since this news event. The Volume Ratio is 19.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock
11/6/2014 4:15:00 PM - PR Newswire
unchange Price Change since this news event. The Volume Ratio is 19.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma Reports Third Quarter 2014 Financial Results
10/29/2014 4:01:00 PM - PR Newswire
▼-2.88 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy
10/27/2014 2:30:00 AM - PR Newswire
▼-1.67 % Price Change since this news event. The Volume Ratio is 0.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014
10/20/2014 1:30:00 AM - PR Newswire
▲3.51 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day